Who founded Viridian Therapeutics?

Viridian Therapeutics was founded by Jonathan Violin in 2020.

Who are Viridian Therapeutics's investors?

Viridian Therapeutics's investors include Broadview Ventures, Longitude Capital, MRL Ventures Fund.

How much funding has Viridian Therapeutics raised?

Viridian Therapeutics has disclosed $29M raised across 2 rounds.

Where is Viridian Therapeutics headquartered?

Viridian Therapeutics is headquartered in Waltham, US.

Viridian Therapeutics

Waltham, US · Founded 2020 · Delaware corporation · 3 known investors

Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.

Biotech Digital Health Medical Devices

Founders & leadership

Viridian Therapeutics was founded in 2020 by Jonathan Violin.

Jonathan ViolinFounder

Board

Peter HarwinBoard director

Tomas KiselakBoard director

Investors · 3

Broadview VenturesBoston

Longitude CapitalMenlo Park · $10M – $30M

MRL Ventures FundCambridge · $25M

Reported raises · per SEC filings

Form D private placements

$29M disclosed across 2 rounds · 2020

▶$27MraisedSep 2020 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jonathan ViolinExecutive Officer, Director
Tomas KiselakDirector
Peter HarwinDirector

Offering amount: $27M
Amount sold: $27M
First sale: Sep 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMay 2020 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Jonathan ViolinExecutive Officer, Director
Peter HarwinDirector
Tomas KiselakDirector

Offering amount: $5M
Amount sold: $2M
First sale: Apr 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Bioworld59 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Viridian Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Viridian Therapeutics do?: Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
Who founded Viridian Therapeutics?: Viridian Therapeutics was founded by Jonathan Violin in 2020.
Who are Viridian Therapeutics's investors?: Viridian Therapeutics's investors include Broadview Ventures, Longitude Capital, MRL Ventures Fund.
How much funding has Viridian Therapeutics raised?: Viridian Therapeutics has disclosed $29M raised across 2 rounds.
Where is Viridian Therapeutics headquartered?: Viridian Therapeutics is headquartered in Waltham, US.